. .
.. ,
.. , ..
. ..
.
(),
(, 2013
.).
.
:
,
-
,
GERD Q,
.
: , -,
, GERD Q.
The aim of review. To demonstrate most
pressing issues of diagnostics and treatment of
gastroesopha-geal reflux disease (GERD),
presented in abstracts of the World
gastroenterological congress (China, 2013).
Key points. Following tendencies and
advances deserve the highest attention: wide
introduction of new diagnostics methods of GERD
in the last years, e.g.: -impedance
measurement and high resolution manometry,
development of new method of non-invasive GERD
diagnostics at primary healthcare stage -GERD Q
questionnaire, optimization of GERD treatment
and its complications.
Key words: GERD, -impedance
measurement, high resolution manometry, GERD Q
questionnaire.
21 24 2013 .
,
-
.
,
, ,
.
().
:
,
,
. ,
,
, ,
, ,
,
[1].
(),
-
,
, .
, [2].
,
. ,
,
()
-
,
,
[3].
,
,
.
, D. C. Sudipta . [4]
6639
.
,
13,6% , 24,2%
, 19,1%
.
: ,
, , - ,
(, ),
,
. ,
,
40 , ,
.
I. Chirila
. [5]
.
Gastrointestinal Symptom Rating Scale (GSRS),
, 31,1%
. 50
(37,4%),
(41,1%).
. .
. [6]
, ,
(
). 14 270
, 572 , 1489 ,
. ,
, ,
1,5%, - 4,4%, - 2,9%.
,
.
. . . [7]
GERD Q .
,
.. ,
- .. ,
.. , 150 ,
GERD Q,
6 (
8 ),
-
.
,
GERD Q
65,4%, 91,7%.
,
-
(, -)
.
GERD Q M. Sandu . [8],
105
, ,
(),
, ,
, .
GERD Q,
8 .
43 (40,9%) 105 ,
.
,
(45%), 15 36
(41,6%), 1 6 , 4
5 , 2 6
, 2 7
, 1 5 .
,
,
,
.
O. Barboi [9]
24 ,
(6
), (17 ),
(1 ). ,
,
,
/
.
: (45,83%),
- (16,66%),
(37,51%).
,
,
, ,
,
.
Xuan Jiang [10] ,
()
- ().
, 25,2%
, 14% , 10,3%
, 7,5%
.
,
-
.
Zhou Liya . [11]
-
- . 667
, ,
-
352 . ,
- -
,
.
.
,
-
- 20%.
Yinan Shi . [12]
()
96 , 59
().
,
DCI-
,
.
,
-.
( 1078,5697 950616 . .c)
(CFV):
4,81,5 4,41,4 /.
, ,
,
,
.
F. Dai . [13]
-
.
132 , ,
, 32 .
-
SAP (
), (- ) 48
(36%), (-
, SAP ) 51 (39%),
(- , SAP
) 33 (25%). ,
,
.
,
,
(16,54,8 26,35,7 . . ).
.
400
, 39
, [14].
, 32%
,
2 ,
. 87%
, 70%
, 17%
, 38%
.
,
. Yinan Shi
. [15], 24-
-
,
.
117
,
.
20 2
4 .
,
1 .
44 .
,
, ,
, ,
.
,
- ,
-
( ).
, ,
-
( ),
- ,
.
Eun Hye Kim . [16]
24- -
.
45 ,
.
.
( ):
2
,
3 .
,
,
.
- ,
, ,
(4,4 19,3 ),
(28 21,7).
:
- -,
,
.
,
,
,
.
.
K. Wang . [17],
,
. ,
, -
,
: 39
-,
19
-, 10
, 12 .
.
,
,
,
,
. ,
.
.
,
( )
.
Yan Xue . [18] 356
. pylori
.
. pylori
:
56- 20 2
, 10-
(,
, ) 46-
20 2 .
,
. pylori,
8 .
8- .
8- 81,8%
, ,
78,2% . 8
, . pylori,
82,6%
(=0,462).
, ,
. pylori
.
J. Wu . [19]
.
24 ,
,
5 . .,
5% ,
,
3 .
,
12 30 .
3
6 (GERD-HRQL),
,
- ( 4)
.
,
31 (2537), 3-
,
4 (211).
-,
11,3% 3,3% 3
2,6% 6 .
- .
n. ,
W. Zhu . [20] 46
(20 2 48
).
1, 6 12
.
, 40
, 6
.
6 .
,
,
,
,
,
,
.
,
,
,
.
,
,
:
, -
,
GERD Q.
,
Journal of
Gastroenterology and Hepatology,
http://onlinelibrary.wiley.com doi/10.1111/jgh.2013.28.issue-s3/issuetoc.
1. .., .., ..,
.
.
. ., 2005.
1. Ivashkin V.T., Sheptulin A.A., Trukhmanov
A.S., et al. Guidelines on investigation and
treatment of patients by gastroesophageal reflux
disease. manual for physicians. ., 2005.
2.
.., .., .., .
GERD Q
. . .
. . . 2013;
21(5):15-23.
2. Kaybysheva V.O., Kucheryavy YUA, Trukhmanov
A.S., et al. Results of multicenter observational
study on application of international
questionnaire GERD Q for diagnostics of
gastroesophageal reflux disease. Ros zhurn
gastroenterol gepatol koloproktol 2013;
21(5):15-23.
3. .., .., ..
,
. . . . .
. 2011; 21(4):4-13.
3. Kaybysheva V.O., Trukhmanov A.S., Ivashkin
V.T. Gastroesophageal reflux disease, resistant to
proton pump inhibitors. Ros zhurn gastroenterol
gepatol koloproktol 2011; 21 (4) : 4-13.
4. Sudipta D.C., Gemlyn G, Kartik R, et al.
Prevalence and associations of gastroesophageal
reflux disease: A community study in South India.
J Gastroenterol Hepatol 2013; 28 (suppl. 3):510.
5. Chirila I., Petrariu F., Drug V., et al.
Epidemiology of gastroesophageal reflux and
relationship with diet in adult urban population.
J Gastroenterol Hepatol 2013; 28 (suppl. 3):503.
6. Tsukanov V., Butorin N., Bichurina T., et al.
The prevalence of Barretts esophagus in europoids
and mongoloids of Siberia. J Gastroenterol Hepatol
2013; 28 (suppl. 3):69.
7. Kaibysheva V., Ivashkin V., Troukhmanov A.,
Maev I., et al. Validation of Gerd Q questionnaire
for diagnosis of gastroesophageal reflux disease (GERD)
in Russia. J Gastroenterol Hepatol 2013; 28 (suppl.
3):81.
8. Sandu M, Barboi O, Drug V, et al.
Gastroesophageal reflux disease in respiratory
disorders. J Gastroenterol Hepatol 2013; 28 (suppl.
3):513.
9. Barboi O, Drug V, et al. Atypical
manifestations of gastroesophageal reflux disease.
J Gastroenterol Hepatol 2013; 28 (suppl. 3):310.
10. Xuan Jiang, Yan H, Peng X, et al. Study on
the characteristics of gastroesopheal reflux
disease overlap with functional bowl diseases in
GI clinic. J Gastroenterol Hepatol 2013; 28 (suppl.
3):511.
11. Zhou Liya, Wang Ye, Lin Sanren, et al.
Accuracy of the diagnosis of GERD by esophageal
impedance monitoring. J Gastroenterol Hepatol
2013; 28 (suppl. 3):506.
12. Yinan Shi, Xiao Y, Chen M, et al.
Esophageal peristalsis of gastroesophageal reflux
disease patients in high-resolution manometry. J
Gastroenterol Hepatol 2013; 28 (suppl. 3):62.
13. Dai F, Cheng Y, Chen F, et al. The value of
impedance-pH monitoring and esophagus manometry in
differentiaing NERD and FH. J Gastroenterol
Hepatol 2013; 28 (suppl. 3):526.
14. Pittayanon R, Vilaichone R, Patcharatrakul
T, et al. Quantitative patient survey of GERD in
Thailand the pattern of PPI use. J Gastroenterol
Hepatol 2013; 28(suppl. 3):294.
15. Yinan Shi, Xiao Y, Chen M, et al.
Predictors for proton pump inhibitor failure in
non-erosive gastroesophageal reflux disease. J
Gastroenterol Hepatol 2013; 28 (suppl. 3):60.
16. Eun Hye Kim, Lee D, Park K, et al.
Evaluation of efficacy of proton pump inihibitors
in refractory gastroesophageal reflux disease. J
Gastroenterol Hepatol 2013; 28(suppl. 3):290.
17. Wang K, Duan L-P, Ge Y, et al. The roles of
weakly acidic reflux in esophageal endoscopic and
microscopic abnormalities. J Gastroenterol Hepatol
2013; 28 (suppl. 3):508.
18. Yan Xue, Zhou L, Lin S, et al. The effect
of H. pylori eradication on the therapy of reflux
esophagitis. J Gastroenterol Hepatol 2013; 28 (suppl.
3):504.
19. Wu J, Siersema P, Bredenoord A, et al.
Electrical stimulation of the lower esophageal
sphincter successful in treating refractory GERD.
J Gastroenterol Hepatol 2013; 28 (suppl. 3):529.
20. Zhu W. Early therapeutic analysis on the
treatment of Barretts esophagus with argon plasma
coagulation. J Gastroenterol Hepatol 2013; 28 (suppl.
3):752.
http://www.gastroscan.ru